Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.7127 per EA under NDC 62332041310. Its NADAC has been published 348 times since Oct 30, 2019.
Strength
30 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332041310
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA211823On Market Since
6/25/2019
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 348 times since Oct 30, 2019, and over the history we have for it it has declined 87.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7127 per EA |
|---|---|
| All-time high | $5.6422 (Nov 13, 2019) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6013 |
| Median price | $1.4011 |
| Average price | $1.8403 |
| Largest weekly change | +62.9% (Jan 25, 2023) |
| Weeks tracked | 348 |
| Tracking since | Oct 30, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the OSELTAMIVIR market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.7127 per EA (NDC 62332041310), effective Jun 24, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 87.4%. It has been tracked across 348 weekly CMS publications since Oct 30, 2019.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Oct 30, 2019, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $5.6422 (Nov 13, 2019), with a median of $1.4011 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OSELTAMIVIR PHOS 30 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 62332041310) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification